Literature DB >> 4726270

Study of creatine phosphokinase, lactic dehydrogenase and transaminases in neuromuscular diseases.

R S Singh, S P Agrawal, S K Dikshit.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4726270     DOI: 10.1007/BF02750182

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  11 in total

1.  SERUM ENZYME STUDIES IN MUSCLE DISEASE. II. SERUM CREATINE KINASE ACTIVITY IN MUSCULAR DYSTROPHY AND IN OTHER MYOPATHIC AND NEUROPATHIC DISORDERS.

Authors:  J M PEARCE; R J PENNINGTON; J N WALTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-04       Impact factor: 10.154

2.  THE USE OF SERUM CREATINE PHOSPHOKINASE AND OTHER SERUM ENZYMES IN THE DIAGNOSIS OF PROGRESSIVE MUSCULAR DYSTROPHY.

Authors:  K F SWAIMAN; B SANDLER
Journal:  J Pediatr       Date:  1963-12       Impact factor: 4.406

3.  SERUM CREATINE PHOSPHOKINASE (CPK) ACTIVITY IN DISORDERS OF HEART AND SKELETAL MUSCLE.

Authors:  J W HESS; R P MACDONALD; R J FREDERICK; R N JONES; J NEELY; D GROSS
Journal:  Ann Intern Med       Date:  1964-12       Impact factor: 25.391

4.  Serum creatine phosphokinase. Activity in progressive muscular dystrophy and neuromuscular diseases.

Authors:  S OKINAKA; H KUMAGAI; S EBASHI; H SUGITA; H MOMOI; Y TOYOKURA; Y FUJIE
Journal:  Arch Neurol       Date:  1961-05

5.  Serum enzyme activity in muscular dystrophy.

Authors:  W H THOMSON; P LEYBURN; J N WALTON
Journal:  Br Med J       Date:  1960-10-29

6.  Glutamic oxalacetic transaminase activity in the serum in muscular dystrophy and other neuromuscular disorders in childhood.

Authors:  E G MURPHY; M M CHERNIAK
Journal:  Pediatrics       Date:  1958-12       Impact factor: 7.124

7.  Serum enzymes in carriers of muscular dystrophy.

Authors:  B P HUGHES
Journal:  Br Med J       Date:  1962-10-13

8.  Serum enzymes in muscular dystrophy and certain other muscular and neuromuscular diseases. I. Serum glutamic oxalacetic transaminase.

Authors:  C M PEARSON
Journal:  N Engl J Med       Date:  1957-06-06       Impact factor: 91.245

9.  Serum glutamic oxalacetic transaminase in certain neurologic and neuromuscular diseases.

Authors:  R G SIEKERT; G A FLEISHER
Journal:  Proc Staff Meet Mayo Clin       Date:  1956-08-08

10.  Histopathological features of muscle in the preclinical stages of muscular dystrophy.

Authors:  C M PEARSON
Journal:  Brain       Date:  1962-03       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.